← Leaderboards
Rachel A Fissell
University Of Michigan At Ann Arbor
$51,123
Attributed
$51,123
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $35.2K · FY2005–07$50K$37.5K$25K$12.5K$0
'05
'06
'07
Funding mix
By agency
NIH$51,123 · 3
By mechanism
M01$51,123 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Akinlolu O Ojo$28,267,036
- Friedhelm Hildebrandt$22,945,432
- Douglas Earl Schaubel$12,013,133
- Dean E. Brenner$31,108,993
- Jonathan S Bromberg$26,279,150
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsBloodBlood FilterComputer Retrieval Of Information On Scientific Projects DatabaseCrosslinkDeglutitionDialysis ProcedureDietDrinkingEatingEnd Stage Renal FailureFecesFundingGrantHemodialysisHemorrhageImmune SystemInfectionInstitutionIntestinesKidneyKidney FailureKidney TransplantationLearning
Grant awards (4)
SAFETY, EFFICACY, & TOLERABILITY OF CLP IN HEMODIALYSIS DEPENDENT PATIENTS$35,249
M01 · FY2007 · RR · contact PI
GRAFT FUNCTION IN A CROSS SECTION OF RENAL TRANSPLANT RECIPIENTS$5,621
M01 · FY2006 · RR · contact PI
TRIAL TO ASSESS THE SAFETY, EFFICACY, TOLERABILITY OF CLP IN HEMODIALYSIS DEPEND$5,621
M01 · FY2006 · RR · contact PI
GRAFT FUNCTION IN A CROSS SECTION OF RENAL TRANSPLANT RECIPIENTS$4,632
M01 · FY2005 · RR